We analyzed TCGA datasets to research the prognostic value of ANGPTL3 for RCC patients and found that patients with higher ANGPTL3 expression exhibited a shorter OS and DFS of RCC patients. This evidence concerns the gene ANGPTL3 and renal cell carcinoma.